Drugs

Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference

SOUTH SAN FRANCISCO, CA: Groundbreaking Disease-Modifying Treatment for SCD Is Focus of Oral and Poster Presentations ...

Joseph Lobacki to Become Medivation's Chief Commercial Officer

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 11/25/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Joseph Lobacki will join the company as chief commercial officer on December 8, 2014. In this po ...

New PSA Reminds College Students That Vaccination Is the Best Form of Protection Against Dangerous Flu Virus

KING OF PRUSSIA, PA: College Population's Low Vaccination Rates, High-Touch Living Spaces Pose Increased Risk ...

New Federal Funding Enables CDRD and CDRD Ventures Inc. to Expand Support to Canadian Entrepreneurs

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/21/14 -- This morning at the BC Technology Industry Association, The Honourable James Moore, Minister of Industry announced that The Centre for Drug ...

Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 11/19/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...

Medifocus Inc.'s Form 20-F Registration Statement Becomes Effective Immediately

COLUMBIA, MD and TORONTO, ON: COLUMBIA, MD and TORONTO, ON -- (Marketwired) -- 11/19/14 -- (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that its Registration Statement on Form 20-F that was filed with the U.S. Securities and ...

Vanc Pharmaceuticals Receives Health Canada Approval for 22 Generic Molecules

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/18/14 -- Vanc Pharmaceuticals Inc. ("Vanc" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF) is pleased to announce that it ha ...

Merus Labs International Inc. Announces Normal Course Issuer Bid

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/17/14 -- Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) announced today that it is proceeding with a no ...

Matica Enterprises Inc.: Corporate Update on Completed Nova Scotia MMPR Facility With "Ready to Build" Status

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/14/14 -- Matica Enterprises Inc. (CSE: GRF)(FRANKFURT: 39N) ("Matica" or the "Company") is pleased to provide an update on the signing of ...

Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/12/14 -- Horizon Pharma plc (NASDAQ: HZNP) today announced that four abstracts related to RAYOS (prednisone) delayed-release tablets and one abstract on VIMOVO ...